Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
17,787,059
-
Share change
-
-496,825
-
Total reported value
-
$74,549,808
-
Put/Call ratio
-
25%
-
Price per share
-
$4.19
-
Number of holders
-
89
-
Value change
-
-$8,090,953
-
Number of buys
-
40
-
Number of sells
-
45
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2021
As of 31 Dec 2021 Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,787,059 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Skylands Capital, LLC, AVENIR CORP, Neuberger Berman Group LLC, Granahan Investment Management, LLC, Sargent Investment Group, LLC, STATE STREET CORP, Redmile Group, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 89 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.